Angelica archangelica / Garden Angelica / ROS Cancer Research Results

Ang, Angelica archangelica / Garden Angelica: Click to Expand ⟱

Features:

Angelica archangelica (Garden angelica) is a medicinal plant whose root, leaf, seed, and essential-oil preparations contain coumarins, furanocoumarins, and volatile terpenes. Major reported constituents include imperatorin, isoimperatorin, xanthotoxin, bergapten, α-pinene, and β-phellandrene. Preclinical studies report anticancer, antimicrobial, anti-inflammatory, antioxidant, and gastrointestinal effects. The plant part and extraction method should be recorded because constituent profiles vary substantially. Angelica archangelica should be kept separate from other Angelica species, including Angelica sinensis. Concentrated preparations may contain phototoxic furanocoumarins and can increase photosensitivity. Research reference; Safety reference.

Angelica archangelica / Garden Angelica — a large aromatic biennial herb in the Apiaceae family used as a culinary botanical and traditional herbal preparation. It is a heterogeneous plant-derived modality rather than a single pharmacological agent; roots, fruits or seeds, leaves, and essential oils have substantially different chemical profiles. Standard names include Angelica archangelica L., garden angelica, European angelica, and the historical synonym Archangelica officinalis. Important constituents include the furanocoumarins imperatorin, isoimperatorin, xanthotoxin, bergapten, and angelicin, together with volatile terpenes such as α-pinene and β-phellandrene. Anticancer evidence applies mainly to chemically undefined root or fruit extracts and cannot automatically be attributed to the whole plant, essential oil, or any single constituent.

Primary mechanisms (ranked):

Induction of intrinsic and extrinsic apoptotic signaling in susceptible cancer cells, including caspase activation, mitochondrial dysfunction, and increased pro-apoptotic signaling.
Suppression of tumor-cell proliferation and clonogenic survival, with cell-cycle disruption reported in extract-treated breast and leukemia models.
Modulation of oxidative stress and mitochondrial function, potentially contributing to apoptosis; the direction and importance of ROS remain extract-, concentration-, and model-dependent.
Possible inhibition of inflammatory and survival signaling by coumarins and furanocoumarins, including NF-κB-, MAPK-, and Akt-related pathways; direct evidence for standardized A. archangelica preparations is limited.
Antimicrobial activity of volatile-oil constituents through membrane disruption and related nonspecific physicochemical effects.

Bioavailability / PK relevance: Human pharmacokinetic data for standardized A. archangelica extracts are insufficient. Exposure varies markedly with plant part, cultivar, geography, harvest conditions, and extraction method. Lipophilic furanocoumarins and essential-oil terpenes may be absorbed, but metabolism and systemic concentrations after ordinary oral products are poorly characterized. Root powder, hydroalcoholic extract, essential oil, and isolated furanocoumarins should be treated as distinct preparations.

In-vitro vs systemic exposure relevance: Most anticancer findings were generated using concentrated extracts directly applied to cultured cells. These exposures cannot presently be mapped reliably to achievable human plasma or tissue concentrations. Essential-oil antimicrobial concentrations and isolated-compound experiments are especially unlikely to represent exposure from culinary use. The available evidence therefore supports mechanistic plausibility, not a clinically validated anticancer dose.

Clinical evidence status: Preclinical for cancer. Evidence includes cancer-cell experiments and limited animal tumor studies, without convincing human oncology trials. Small randomized and observational human studies have evaluated a combination supplement containing ferulic acid plus A. archangelica extract in mild cognitive impairment or dementia-related symptoms, but these studies do not establish an independent effect of angelica. It is not an approved cancer therapy or established adjunctive oncology treatment.

Safety and deployment status: Culinary use and traditional herbal use do not establish the safety of concentrated extracts or essential oils. Furanocoumarins can produce UVA-dependent phototoxicity and photogenotoxicity; concentrated preparations may increase photosensitivity, and exposure to strong sunlight or UVA is a material safety concern. Botanical misidentification is also important because Apiaceae includes highly toxic look-alike plants. Safety in pregnancy, breastfeeding, children, and long-term high-dose use is inadequately defined.

Angelica archangelica Mechanistic Profile

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	Apoptosis Signaling	Caspases ↑; apoptotic death ↑	Insufficient species-specific evidence	R, G	Promotes programmed cancer-cell death	Reported with root and fruit extracts in breast-cancer and leukemia models. Extract composition was not consistently standardized.
2	Mitochondrial Apoptosis	Mitochondrial integrity ↓; pro-apoptotic signaling ↑	↔ or uncertain	R, G	Supports intrinsic apoptosis	Likely contributes to extract-induced cytotoxicity, but the responsible constituent and precise mitochondrial targets remain incompletely resolved.
3	Proliferation and Clonogenic Survival	Proliferation ↓; colony formation ↓	Insufficient comparative evidence	G	Restricts tumor-cell expansion	Observed preclinically. Selectivity relative to normal proliferating tissue is not sufficiently established.
4	Cell-Cycle Regulation	Cell-cycle progression ↓ (model-dependent)	Uncertain	R, G	Contributes to growth inhibition	Cell-cycle effects are reported for extracts or related coumarins, but a reproducible species-wide signature has not been established.
5	Oxidative Stress and ROS	ROS ↔ or ↑ (context-dependent)	Oxidative injury ↓ in some non-cancer models	P, R	Context-dependent redox modulation	Antioxidant assay activity does not prove systemic antioxidant action. Pro-oxidant involvement in cancer-cell apoptosis remains preparation- and concentration-dependent.
6	NF-κB and Inflammatory Signaling	NF-κB ↓; inflammatory mediators ↓ (context-dependent)	Inflammation ↓ in selected models	R, G	May reduce inflammatory and survival signaling	More strongly supported for isolated coumarins or other Angelica species than for standardized A. archangelica whole extracts.
7	Akt and MAPK Survival Signaling	Akt or MAPK signaling ↓ (model-dependent)	Mixed or uncertain	R	Potentially lowers proliferative and stress-survival signaling	Mechanistically plausible from constituent studies, but should not be treated as a firmly established whole-plant mechanism.
8	Microbial Membrane Function	Not primarily cancer-specific	Host-cell relevance uncertain	P	Essential-oil antimicrobial activity	Volatile terpenes can disrupt microbial membranes at sufficient concentrations. This does not establish systemic anti-infective efficacy.
9	UVA Phototoxicity and DNA Damage	Phototoxicity ↑ with UVA	Phototoxicity ↑; photogenotoxicity ↑	P, R	Furanocoumarin photoactivation	Safety liability rather than a validated therapeutic mechanism. Risk depends on furanocoumarin content, exposure, skin or systemic distribution, and UVA dose.
10	Clinical Translation Constraint	Effective human exposure unknown	Long-term safety incompletely characterized	G	Limits interpretation and deployment	Major constraints include extract heterogeneity, uncertain PK, predominantly preclinical evidence, lack of oncology trials, botanical misidentification, and phototoxic furanocoumarins.

TSF: P: 0–30 min R: 30 min–3 hr G: >3 hr

Alzheimer’s disease relevance: Human evidence involves Feru-guard formulations combining ferulic acid with Angelica archangelica extract; consequently, clinical effects cannot be assigned specifically to angelica. A multicenter randomized placebo-controlled study in mild cognitive impairment reported selected cognitive benefits, while an amyloid-imaging study did not demonstrate a clear reduction in cerebral amyloid deposition. Earlier small studies reported possible behavioral or neuropsychiatric improvement in heterogeneous dementia populations. Overall status is small human combination-product evidence with mixed outcomes, not established prevention or treatment of Alzheimer’s disease.

Primary AD-related mechanisms: Proposed mechanisms include AChE inhibition, antioxidant and anti-inflammatory activity, neuronal protection, and possible modulation of amyloid-associated injury. Most are derived from preclinical extract or constituent studies. There is insufficient evidence that orally administered A. archangelica independently reaches the brain at concentrations required for these effects.

Angelica archangelica in Cognitive Disorders

Rank	Pathway / Axis	Modulation	TSF	Primary Effect	Notes / Interpretation
1	Cognitive Function	Cognition ↑ or ↔	G	Possible symptomatic benefit	Mixed findings from small studies of a ferulic-acid plus angelica combination. Independent angelica contribution is unresolved.
2	Cholinergic Signaling	AChE ↓ (preclinical)	R	May increase synaptic acetylcholine	Primarily extract-level preclinical evidence; human target engagement has not been demonstrated.
3	Neuroinflammation	NF-κB ↓; inflammatory mediators ↓ (context-dependent)	R, G	Potential neuroprotective signaling	Evidence is indirect and partly extrapolated from constituent or non-neural models.
4	Oxidative Stress	ROS-associated injury ↓ (preclinical)	P, R	May reduce oxidative neuronal stress	Systemic and brain exposure sufficient for this effect has not been established.
5	Amyloid Beta	Aβ deposition ↔ or uncertain	G	No established disease-modifying effect	A small human imaging study of the combination product did not provide convincing evidence of reduced amyloid deposition.
6	Clinical Translation Constraint	Independent efficacy uncertain	G	Limits attribution and clinical interpretation	Combination with ferulic acid, small samples, heterogeneous diagnoses, limited replication, and uncertain brain PK prevent product-specific conclusions.

TSF: P: 0–30 min R: 30 min–3 hr G: >3 hr

ROS, Reactive Oxygen Species: Click to Expand ⟱

Source: HalifaxProj (inhibit)

Type:

Reactive oxygen species (ROS) are highly reactive molecules that contain oxygen and can lead to oxidative stress in cells. They play a dual role in cancer biology, acting as both promoters and suppressors of cancer.
ROS can cause oxidative damage to DNA, leading to mutations that may contribute to cancer initiation and progression. So normally you want to inhibit ROS to prevent cell mutations.
However excessive ROS can induce apoptosis (programmed cell death) in cancer cells, potentially limiting tumor growth. Chemotherapy typically raises ROS.
-mitochondria is the main source of reactive oxygen species (ROS) (and the ETC is heavily related)
ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target

"Reactive oxygen species (ROS) are two electron reduction products of oxygen, including superoxide anion, hydrogen peroxide, hydroxyl radical, lipid peroxides, protein peroxides and peroxides formed in nucleic acids 1. They are maintained in a dynamic balance by a series of reduction-oxidation (redox) reactions in biological systems and act as signaling molecules to drive cellular regulatory pathways."
"During different stages of cancer formation, abnormal ROS levels play paradoxical roles in cell growth and death 8. A physiological concentration of ROS that maintained in equilibrium is necessary for normal cell survival. Ectopic ROS accumulation promotes cell proliferation and consequently induces malignant transformation of normal cells by initiating pathological conversion of physiological signaling networks. Excessive ROS levels lead to cell death by damaging cellular components, including proteins, lipid bilayers, and chromosomes. Therefore, both scavenging abnormally elevated ROS to prevent early neoplasia and facilitating ROS production to specifically kill cancer cells are promising anticancer therapeutic strategies, in spite of their contradictoriness and complexity."
"ROS are the collection of derivatives of molecular oxygen that occur in biology, which can be categorized into two types, free radicals and non-radical species. The non-radical species are hydrogen peroxide (H 2O 2 ), organic hydroperoxides (ROOH), singlet molecular oxygen ( 1 O 2 ), electronically excited carbonyl, ozone (O3 ), hypochlorous acid (HOCl, and hypobromous acid HOBr). Free radical species are super-oxide anion radical (O 2•−), hydroxyl radical (•OH), peroxyl radical (ROO•) and alkoxyl radical (RO•) [130]. Any imbalance of ROS can lead to adverse effects. H2 O 2 and O 2 •− are the main redox signalling agents. The cellular concentration of H2 O 2 is about 10−8 M, which is almost a thousand times more than that of O2 •−".
"Radicals are molecules with an odd number of electrons in the outer shell [393,394]. A pair of radicals can be formed by breaking a chemical bond or electron transfer between two molecules."

Recent investigations have documented that polyphenols with good antioxidant activity may exhibit pro-oxidant activity in the presence of copper ions, which can induce apoptosis in various cancer cell lines but not in normal cells. "We have shown that such cell growth inhibition by polyphenols in cancer cells is reversed by copper-specific sequestering agent neocuproine to a significant extent whereas iron and zinc chelators are relatively ineffective, thus confirming the role of endogenous copper in the cytotoxic action of polyphenols against cancer cells. Therefore, this mechanism of mobilization of endogenous copper." > Ions could be one of the important mechanisms for the cytotoxic action of plant polyphenols against cancer cells and is possibly a common mechanism for all plant polyphenols. In fact, similar results obtained with four different polyphenolic compounds in this study, namely apigenin, luteolin, EGCG, and resveratrol, strengthen this idea.
Interestingly, the normal breast epithelial MCF10A cells have earlier been shown to possess no detectable copper as opposed to breast cancer cells [24], which may explain their resistance to polyphenols apigenin- and luteolin-induced growth inhibition as observed here (Fig. 1). We have earlier proposed [25] that this preferential cytotoxicity of plant polyphenols toward cancer cells is explained by the observation made several years earlier, which showed that copper levels in cancer cells are significantly elevated in various malignancies. Thus, because of higher intracellular copper levels in cancer cells, it may be predicted that the cytotoxic concentrations of polyphenols required would be lower in these cells as compared to normal cells."

Majority of ROS are produced as a by-product of oxidative phosphorylation, high levels of ROS are detected in almost all cancers.
-It is well established that during ER stress, cytosolic calcium released from the ER is taken up by the mitochondrion to stimulate ROS overgeneration and the release of cytochrome c, both of which lead to apoptosis.

Note: Products that may raise ROS can be found using this database, by:
Filtering on the target of ROS, and selecting the Effect Direction of ↑

Targets to raise ROS (to kill cancer cells):
• NADPH oxidases (NOX): NOX enzymes are involved in the production of ROS.
    -Targeting NOX enzymes can increase ROS levels and induce cancer cell death.
    -eNOX2 inhibition leads to a high NADH/NAD⁺ ratio which can lead to increased ROS
• Mitochondrial complex I: Inhibiting can increase ROS production
• P53: Activating p53 can increase ROS levels(by inducing the expression of pro-oxidant genes)
• Nrf2 inhibition: regulates the expression of antioxidant genes. Inhibiting Nrf2 can increase ROS levels
• Glutathione (GSH): an antioxidant. Depleting GSH can increase ROS levels
• Catalase: Catalase converts H2O2 into H2O+O. Inhibiting catalase can increase ROS levels
• SOD1: converts superoxide into hydrogen peroxide. Inhibiting SOD1 can increase ROS levels
• PI3K/AKT pathway: regulates cell survival and metabolism. Inhibiting can increase ROS levels
• HIF-1α inhibition: regulates genes involved in metabolism and angiogenesis. Inhibiting HIF-1α can increase ROS
• Glycolysis: Inhibiting glycolysis can increase ROS levels • Fatty acid oxidation: Cancer cells often rely on fatty acid oxidation for energy production.
-Inhibiting fatty acid oxidation can increase ROS levels
• ER stress: Endoplasmic reticulum (ER) stress can increase ROS levels
• Autophagy: process by which cells recycle damaged organelles and proteins.
-Inhibiting autophagy can increase ROS levels and induce cancer cell death.
• KEAP1/Nrf2 pathway: regulates the expression of antioxidant genes.
    -Inhibiting KEAP1 or activating Nrf2 can increase ROS levels and induce cancer cell death.
• DJ-1: regulates the expression of antioxidant genes. Inhibiting DJ-1 can increase ROS levels
• PARK2: regulates the expression of antioxidant genes. Inhibiting PARK2 can increase ROS levels
• SIRT1 inhibition:regulates the expression of antioxidant genes. Inhibiting SIRT1 can increase ROS levels
• AMPK activation: regulates energy metabolism and can increase ROS levels when activated.
• mTOR inhibition: regulates cell growth and metabolism. Inhibiting mTOR can increase ROS levels
• HSP90 inhibition: regulates protein folding and can increase ROS levels when inhibited.
• Proteasome: degrades damaged proteins. Inhibiting the proteasome can increase ROS levels
• Lipid peroxidation: a process by which lipids are oxidized, leading to the production of ROS.
    -Increasing lipid peroxidation can increase ROS levels
• Ferroptosis: form of cell death that is regulated by iron and lipid peroxidation.
    -Increasing ferroptosis can increase ROS levels
• Mitochondrial permeability transition pore (mPTP): regulates mitochondrial permeability.
    -Opening the mPTP can increase ROS levels
• BCL-2 family proteins: regulate apoptosis and can increase ROS levels when inhibited.
• Caspase-independent cell death: a form of cell death that is regulated by ROS.
    -Increasing caspase-independent cell death can increase ROS levels
• DNA damage response: regulates the repair of DNA damage. Increasing DNA damage can increase ROS
• Epigenetic regulation: process by which gene expression is regulated.
    -Increasing epigenetic regulation can increase ROS levels

-PKM2, but not PKM1, can be inhibited by direct oxidation of cysteine 358 as an adaptive response to increased intracellular reactive oxygen species (ROS)

ProOxidant Strategy:(inhibit the Mevalonate Pathway (likely will also inhibit GPx)
-HydroxyCitrate (HCA) found as supplement online and typically used in a dose of about 1.5g/day or more
-Atorvastatin typically 40-80mg/day, -Dipyridamole typically 200mg 2x/day Combined effect research
-Lycopene typically 100mg/day range (note debatable as it mainly lowers NRF2)

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

ROS-Inducing Interventions in Cancer — Canonical + Mechanistic Reference
-generated from AI and Cancer database
ROS rating:  +++ strong | ++ moderate | + weak | ± mixed | 0 none
NRF2:        ↓ suppressed | ↑ activated | ± mixed | 0 none
Conditions:  [D] dose  [Fe] metal  [M] metabolic  [O₂] oxygen
             [L] light [F] formulation [T] tumor-type [C] combination


Item  ROS↑  NRF2  Condition  Mechanism Class  Remarks  

ROS">Piperlongumine
+++  ↓  [D][T]  ROS-dominant
Selective <span class="wphighlight">ROS</span> stressor, Prevents compensatory upregulation of NRF2, ie GSH↓



ROS">Shikonin
+++ ↓/± [D][T] ROS-dominant
<span class="wphighlight">ROS</span> + glycolysis + GPX4 inhibition



ROS">Vitamin K3 (menadione)
+++ ↓ [D] ROS-dominant
Quinone redox cycler; toxicity limits use



ROS">Copper (ionic / nano)
+++ ↓ [Fe][F] ROS-dominant
Fenton-type redox chemistry



ROS">Sodium Selenite
+++ ↓ [D] ROS-dominant
Pro-oxidant, depletes GSH



ROS">Juglone
+++ ↓ [D] ROS-dominant
Strong quinone <span class="wphighlight">ROS</span> chemistry



ROS">Auranofin
+++ ↓ [D] ROS-dominant
TrxR inhibition → redox collapse



ROS">Photodynamic Therapy (PDT)
+++ 0 [L][O₂] ROS-dominant
Singlet oxygen is core cytotoxic mechanism



ROS">Radiotherapy / Radiation
+++ 0 [O₂] ROS-dominant
DNA damage largely via <span class="wphighlight">ROS</span>



ROS">Doxorubicin
+++ ↓ [D] ROS-dominant
Chemo; redox cycling + mitochondrial <span class="wphighlight">ROS</span>



ROS">Cisplatin
++ ↓ [D][T] ROS-dominant
<span class="wphighlight">ROS</span> contributes to DNA/protein damage



ROS">Salinomycin
++ ↓ [D][T] ROS-dominant
<span class="wphighlight">ROS</span>-mediated CSC toxicity



ROS">Artemisinin / DHA
++ ↓ [Fe][T] ROS-dominant
Iron-activated radical generation



ROS">Sulfasalazine
++ ↓ [C][T] ROS-dominant
Ferroptosis; xCT inhibition → lipid <span class="wphighlight">ROS</span>



ROS">FMD / fasting
++ ↓ [M][C][O₂] ROS-dominant
Metabolic stress → mitochondrial <span class="wphighlight">ROS</span>



ROS">Vitamin C (pharmacologic)
++ ↓ [Fe][D] ROS-dominant
Extracellular H₂O₂ at high dose



ROS">Silver nanoparticles
++ ± [F][D] ROS-dominant
<span class="wphighlight">ROS</span> common; selectivity unreliable



ROS">Gambogic acid
++ ↓ [D][T] ROS-dominant
<span class="wphighlight">ROS</span>-mediated apoptosis



ROS">Parthenolide
++ ↓ [D][T] ROS-dominant
<span class="wphighlight">ROS</span> + NF-κB suppression



ROS">Plumbagin
++ ↓ [D] ROS-dominant
Quinone <span class="wphighlight">ROS</span> driver



ROS">Allicin
++ ↓ [D] ROS-dominant
Thiol-reactive oxidative stress



ROS">Ashwagandha (Withaferin A)
++ ↓ [D][T] ROS-dominant
<span class="wphighlight">ROS</span>-mediated apoptosis



ROS">Berberine
++ ↓ [D][M] ROS-dominant
Mitochondrial <span class="wphighlight">ROS</span> induction



ROS">PEITC
++ ↓ [D][C] ROS-dominant
GSH depletion + <span class="wphighlight">ROS</span>



ROS">Methionine restriction
+ ↓ [M][C][T] ROS-secondary
Redox vulnerability increased; <span class="wphighlight">ROS</span> indirect



ROS">DCA
+ ± [M][T] ROS-secondary
<span class="wphighlight">ROS</span> via forced OXPHOS



ROS">Capsaicin
+ ± [D][T] ROS-secondary
Ca²⁺ stress → <span class="wphighlight">ROS</span>



ROS">Galloflavin
+ 0 [D] ROS-secondary
<span class="wphighlight">ROS</span> not primary driver



ROS">Piperine
+ ± [D][F] ROS-secondary
Weak <span class="wphighlight">ROS</span> induction



ROS">Propyl gallate
+ ↓ [D] ROS-secondary
Pro-oxidant at high dose



ROS">Scoulerine
+ ? [D][T] ROS-secondary
Sparse <span class="wphighlight">ROS</span> data



ROS">Thymoquinone
± ± [D][T] Dual redox
Antioxidant ↔ pro-oxidant switch



ROS">Emodin
± ± [D][T] Dual redox
Not cancer-exclusive



ROS">Alpha-lipoic acid (ALA)
± ↑ [D][M] NRF2-dominant
Antioxidant at low dose



ROS">Curcumin
± ↑/↓ [D][F] NRF2-dominant
Hormetic redox behavior



ROS">EGCG
± ↑/↓ [D][O₂] NRF2-dominant
Auto-oxidation artifacts common



ROS">Quercetin
± ↑/↓ [D][Fe] NRF2-dominant
GSH-dependent cycling



ROS">Resveratrol
± ↑ [D][M] NRF2-dominant
<span class="wphighlight">ROS</span> only at high dose



ROS">Sulforaphane
± ↑↑ [D] NRF2-dominant
Strong NRF2 activator



ROS">Lycopene
0 ↑ — Antioxidant
Consistently antioxidant



ROS">Rosmarinic acid
0 ↑ — Antioxidant
Primarily antioxidant



ROS">Citrate
0 0 — Neutral
Metabolic; not a <span class="wphighlight">ROS</span> agent

Scientific Papers found: Click to Expand⟱

6888-

Ang,

Uncovering the Mechanisms of Angelica glauca Edgew. In Breast Cancer: A Combined In Vitro and In Silico Approach

in-vitro,

BC,

MCF7

 IC₅₀ 91.77, 105.59, and 114.02 µg/mL for root, seed, and leaf, respectively

MMP↓, ROS↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Redox & Oxidative Stress(tgid=1) ⓘ

ROS↑, 1,

Mitochondria & Bioenergetics(tgid=3) ⓘ

MMP↓, 1,
Total Targets: 2

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: ROS, Reactive Oxygen Species

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:421  Target#:275  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid